Articles
  

The ITGAV-rs3911238 Polymorphism Is Associated with Disease Activity in Rheumatoid Arthritis

Abstract

Evidences indicate that angiogenesis  is an important process in the development of destructive synovial tissue in rheumatoid  arthritis (RA). Recently, it has been shown that the polymorphism of the integrin-αv subunit encoded by the ITGAV gene plays a role in angiogenesis and is considered  as RA susceptibility loci. This study investigated association of four single nucleotide polymorphisms  (SNPs) in ITGAV with  disease  activity  score (DAS28), serum levels  of  C-reactive protein  (CRP), and  anti-cyclic citrullinated peptide(anti-CCP) antibody in 419 RA patients and 398 healthy individuals. Four SNPs in  ITGAV  gene  (rs3911238, rs3738919, rs10174098 and  rs3768777) were  analyzed.   Serum concentrations of anti-CCP antibody and CRP were measured by ELISA. We used the EULAR activity criteria to calculate DAS28-CRP. Among these SNPs, the ITGAV-rs3911238-G/C polymorphism was associated with RA disease activity  [remission-to-low   and  moderate-to-high  in  codominant   model  (CC vs.GG:  OR=1.53, p=0.041 and allele (C vs. G: OR=1.18, p=0.042)] and presence of anti-CCP (codominant CC vs.GG: OR=2.77, p=0.001,  allele C vs. G:  OR=1.19,p=0.033).  The  carriers  of  CC genotype  ITGAV- rs3911238 had higher serum levels of CRP and anti-CCP antibody titer and higher ESR and disease activity  score than carriers of GG  and CG genotypes. Furthermore, haplotypes  analysis showed that ITGAV rs3733891C/rs3768777T/rs3911238C/rs10174098A and ITGAV rs3733891A/rs3768777T/rs3911238G/rs10174098A haplotypes increased severity and anti-CCP antibody in RA patients (OR=5.54, p=0.049 and OR=2.89;  p=0.024, respectively) in comparison with ITGAV rs3733891C/rs3768777T/rs3911238G/rs10174098A haplotypes. Thus, the present study demonstrated that the link between systemic inflammatory markers and the ITGAV-rs3911238 polymorphism  allele in Iranian RA patients.

 

 

1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365(23):2205-19.
2. Paleolog EM. The vasculature in rheumatoid arthritis:
cause or consequence? Int J Exp Pathol 2009; 90(3):249-61.
3. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci 2006;11:529-43.
4. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct alpha v integrins. Science 1995;270(5241):1500-2.
5. Eliceiri BP, Cheresh DA. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 1999;103(9):1227-30.
6. Stupack DG. Integrins as a distinct subtype of dependence receptors. Cell Death Differ 2005;
12(8):1021-30.
7. Yee KL, Weaver VM, Hammer DA. Integrin-mediated signalling through the MAP-kinase pathway. IET Syst Biol 2008; 2(1):8-15.
8. Zutter MM, Santoro SA, Staatz WD, Tsung YL. Re- expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci U S A 1995; 92(16):7411-5.
9. Horton MA. The alpha v beta 3 integrin "vitronectin receptor". Int J Biochem Cell Biol 1997; 29(5):721-5.
10. Teitelbaum SL. Osteoclasts, integrins, and osteoporosis. J Bone Miner Metab 2000;18(6):344-9.
11. Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res 2010; 339(1):269-80.
12. Westlin WF. Integrins as targets of angiogenesis inhibition. Cancer J 2001; 7 Suppl 3:S139-43.
13. Jacq L, Garnier S, Dieude P, Michou L, Pierlot C, Migliorini P, et al. The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study. Arthritis Res Ther 2007; 9(4):R63.
14. Paleolog EM. Angiogenesis in rheumatoid arthritis.
Arthritis Res 2002; 4 Suppl 3:S81-90.
15. Osorio YFJ, Bukulmez H, Petit-Teixeira E, Michou L, Pierlot C, Cailleau-Moindrault S, et al. Dense genome- wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum 2004; 50(9):2757-65.
16. Pandya NM, Dhalla NS, Santani DD. Angiogenesis--a new target for future therapy. Vascul Pharmacol 2006;44(5):265-74.
17. Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA. Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest 1999; 103(1):47-54.
18. van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;
39(1):34-40.
19. Vaisi-Raygani A, Rahimi Z, Entezami H, Kharrazi H, Bahrhemand F, Tavilani H, et al. Butyrylcholinesterase K variants increase the risk of coronary artery disease in the
population of western Iran. Scand J Clin Lab Invest 2008;
68(2):123-9.
20. Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. G Genet Anal 1999;14(5-
6):143-9.
21. Inamine T, Nakamura M, Kawauchi A, Shirakawa Y, Hashiguchi H, Aiba Y, et al. A polymorphism in the integrin alphaV subunit gene affects the progression of primary biliary cirrhosis in Japanese patients. J Gastroenterol 2011; 46(5):676-86.
22. Medina J, Arroyo AG, Sanchez-Madrid F, Moreno-Otero R. Angiogenesis in chronic inflammatory liver disease. Hepatology 2004; 39(5):1185-95.
23. Arshadi D, Nikbin B, Shakiba Y, Kiani A, Jamshidi AR, Boroushaki MT. Plasma level of neopterin as a marker of disease activity in treated rheumatoid arthritis patients: Association with gender, disease activity and anti-CCP antibody. Int Immunopharmacol 2013; 17(3):763-7.
24. Hollis-Moffatt JE, Rowley KA, Phipps-Green AJ, Merriman ME, Dalbeth N, Gow P, et al. The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets. Arthritis Res Ther
2009; 11(5):R152.
25. Iikuni N, Kobayashi S, Ikari K, Tomatsu T, Hara M, Yamanaka H, et al. ITGAV polymorphism and disease susceptibility in a Japanese rheumatoid arthritis population. Arthritis Res Ther 2007; 9(5):405.
26. Shakiba Y, Koopah S, Jamshidi AR, Amirzargar AA, Masoud A, Kiani A, Niknam MH , Nazari B, Nikbin B. Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Isotypes in Iranian Patients with Rheumatoid Arthritis: Evaluation of Clinical Value and Association with Disease Activity. IJAAI 2014;
13(3):147-56.

Files
IssueVol 13, No 5 (2014) QRcode
SectionArticles
Keywords
Anti-CCP antibody Disease activity score-28 ITGAV Rheumatoid arthritis ITGAV rs3911238
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Shakiba E, Tavilani H, Goodarzi MT, Kiani A, Pourmotabbed T, Vaisi-Raygani A. The ITGAV-rs3911238 Polymorphism Is Associated with Disease Activity in Rheumatoid Arthritis. Iran J Allergy Asthma Immunol. 1;13(5):356-363.